K-877 Extended Release Tablet

pemafibrate · Kowa Company, Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for K-877 Extended Release Tablet, covering 2024-06-20 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Long Term Study of K-877 Extended Release Tablet [Phase 3]